Addex Therapeutics Ltd (ADXN) — Cash Flow Reinvestment Rate

Latest as of December 2020: 0.14x

Addex Therapeutics Ltd (ADXN) has a Cash Flow Reinvestment Rate of 0.14x as of December 2020, reinvesting $96.17K (capex $48.09K plus investments $-48.09K) from operating cash flow of $704.85K. See Addex Therapeutics Ltd free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

0.14x
(Capex + Investments) / Operating CF

Total Reinvested

$96.17K
Capex + Investments

Operating Cash Flow

$704.85K
USD

Capital Expenditures

$48.09K
USD

Addex Therapeutics Ltd Cash Flow Reinvestment Rate (2018–2018)

Historical reinvestment intensity for Addex Therapeutics Ltd across 1 annual periods. For the full cash flow conversion analysis, see ADXN cash flow metrics.

Annual Cash Flow Reinvestment Rate for Addex Therapeutics Ltd (2018–2018)

Year-by-year capital reinvestment analysis for Addex Therapeutics Ltd. See ADXN free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2018 0.03x $56.37K $1.75 Million $9.05K
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow